News
Glaucoma is one of the world’s leading causes of irreversible blindness, and currently, no therapies exist to directly protect retinal ganglion cells (RGC) from degradation and loss. NIH inventors have developed a method to treat glaucoma using exosomes derived from bone marrow-derived mesenchymal
The National Institutes of Health (NIH) has much more to offer potential collaborators than just small business innovation research (SBIR) grants. Attend this free event hosted by Johnson & Johnson’s JLABS to connect with technology transfer experts from the NIH and learn about the myriad of ways
The NIH National Institute of Diabetes and Digestive and Kidney Diseases is seeking a licensee or collaborator for nanobody-antiviral peptide conjugates that act as a one-two punch against viral entry to block HIV from infecting human CD4* T-cells. Potential commercial applications include: a long
Dr. Mark Rohrbaugh, former director of the NIH Office of Technology Transfer (OTT), has been chosen by the Bayh-Dole Coalition as one of their “Faces of American Innovation”. Mark worked at the NIH for over three decades, moving from the National Institute of Allergy and Infectious Diseases, where